Our human islet experiments, where RHOT1 expression and insulin secretion were reduced by silencing all four selected candidates, together with altered methylation and expression in T2D islets, suggest that RHOT1 is a key regulator of insulin secretion in T2D. Here, RHOT1 is linked to type 2 diabetes mellitus.